All Stories

  1. Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents
  2. Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome
  3. Practical Guidance for Food Consumption to Prevent Cardiovascular Disease
  4. Epigenome-Wide Association Study of Thyroid Function Traits Identifies Novel Associations of fT3 With KLF9 and DOT1L
  5. Increased inspired oxygen concentration does not adversely affect oxidative stress and the resolution of inflammation during reperfusion in patients undergoing knee replacement surgery
  6. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
  7. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
  8. DNA methylation and body mass index from birth to adolescence: meta-analyses of epigenome-wide association studies
  9. Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits
  10. Physical activity trajectories from childhood to late adolescence and their implications for health in young adulthood
  11. Changing dietary approaches to prevent cardiovascular disease
  12. Dietary fibre intake and its associations with depressive symptoms in a prospective adolescent cohort
  13. Energy drink intake and metabolic syndrome: A prospective investigation in young adults
  14. Machine Learning-Based DNA Methylation Score for Fetal Exposure to Maternal Smoking: Development and Validation in Samples Collected from Adolescents and Adults
  15. Methylome-Wide Association Study of Central Adiposity Implicates Genes Involved in Immune and Endocrine Systems
  16. Effects of antiemetic doses of dexamethasone on plasma mediators of inflammation resolution and pain after surgery in women
  17. ApoB48-remnant lipoproteins are associated with increased cardiometabolic risk in adolescents
  18. The Effect of Stent Artefact on Quantification of Plaque Features Using Optical Coherence Tomography (OCT): A Feasibility and Clinical Utility Study
  19. ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
  20. MitoQ and CoQ10 supplementation mildly suppresses skeletal muscle mitochondrial hydrogen peroxide levels without impacting mitochondrial function in middle-aged men
  21. Dietary fibre intake and its association with inflammatory markers in adolescents
  22. Mechanisms of the protective effects of nitrate and nitrite in cardiovascular and metabolic diseases
  23. The effect of regular consumption of lupin-containing foods on glycaemic control and blood pressure in people with type 2 diabetes mellitus
  24. Modelling the Effects of Beverage Substitution during Adolescence on Later Obesity Outcomes in Early Adulthood: Results from the Raine Study
  25. Associations of autozygosity with a broad range of human phenotypes
  26. Alcohol and Hypertension—New Insights and Lingering Controversies
  27. Maternal Smoking During Pregnancy Induces Persistent Epigenetic Changes Into Adolescence, Independent of Postnatal Smoke Exposure and Is Associated With Cardiometabolic Risk
  28. Effect of weight loss on neutrophil resolvins in the metabolic syndrome
  29. The Effects of OMEGA-3 Fatty Acid Supplementation Upon Interleukin-12 and Interleukin-18 in Chronic Kidney Disease Patients
  30. Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals
  31. Furosemide reverses medullary tissue hypoxia in ovine septic acute kidney injury
  32. Altered SPMs and age-associated decrease in brain DHA in APOE4 female mice
  33. Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial
  34. Epigenetic Age Acceleration in Adolescence Associates With BMI, Inflammation, and Risk Score for Middle Age Cardiovascular Disease
  35. Evaluation of biomarkers of kidney injury following 4% succinylated gelatin and 6% hydroxyethyl starch 130/0.4 administration in a canine hemorrhagic shock model
  36. Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: An individual participant data meta-analysis
  37. Relationship between pulse pressure and inflammation with left ventricular diastolic dysfunction in chronic kidney disease patients
  38. Relationship Between Vitamin D Status From Childhood to Early Adulthood With Body Composition in Young Australian Adults
  39. Differential SLC6A4 methylation: a predictive epigenetic marker of adiposity from birth to adulthood
  40. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age
  41. Age at menarche and childhood body mass index as predictors of cardio-metabolic risk in young adulthood: A prospective cohort study
  42. Antiemetic doses of dexamethasone and their effects on immune cell populations and plasma mediators of inflammation resolution in healthy volunteers
  43. Association of maternal prenatal smoking GFI1-locus and cardio-metabolic phenotypes in 18,212 adults
  44. Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
  45. F2-isoprostanes affect macrophage migration and CSF-1 signalling
  46. Maternal smoking and low family income during pregnancy as predictors of the relationship between depression and adiposity in young adults
  47. Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  48. Cardiometabolic Risk Factors at 5 Years After Omega-3 Fatty Acid Supplementation in Infancy
  49. The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus
  50. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease
  51. Reprint of: Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease
  52. Dietary patterns, body mass index and inflammation: Pathways to depression and mental health problems in adolescents
  53. Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review
  54. Working (longer than) 9 to 5: are there cardiometabolic health risks for young Australian workers who report longer than 38-h working weeks?
  55. GC-MS Analysis of Lipid Oxidation Products in Blood, Urine, and Tissue Samples
  56. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
  57. Hyperbaric oxygen therapy is not associated with oxidative stress assessed using plasma F2-isoprostanes and isofurans
  58. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial
  59. The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled
  60. Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents
  61. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial
  62. Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease
  63. FATNESS AND FITNESS WITH CARDIO-METABOLIC RISK FACTORS IN ADOLESCENTS
  64. Relationships between depression and anxiety symptoms scores and blood pressure in young adults
  65. Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
  66. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents
  67. A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men
  68. Infant feeding and growth trajectory patterns in childhood and body composition in young adulthood
  69. Early Life Factors, Obesity Risk, and the Metabolome of Young Adults
  70. Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults
  71. Does Furosemide Increase Oxidative Stress in Acute Kidney Injury?
  72. Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis
  73. Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy
  74. Effects of muscle strength and endurance on blood pressure and related cardiometabolic risk factors from childhood to adolescence
  75. F2-Isoprostanes in HDL are bound to neutral lipids and phospholipids
  76. Authors' reply re: Associations of maternal prepregnancy body mass index and gestational weight gain with cardio-metabolic risk factors in adolescent offspring: a prospective cohort study
  77. Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury
  78. Dual Energy X-Ray Absorptiometry Compared with Anthropometry in Relation to Cardio-Metabolic Risk Factors in a Young Adult Population: Is the ‘Gold Standard’ Tarnished?
  79. Prenatal omega-3 fatty acid supplementation does not affect offspring telomere length and F2-isoprostanes at 12 years: A double blind, randomized controlled trial
  80. Neglecting legumes has compromised human health and sustainable food production
  81. Controlled moderate hypovolaemia in healthy volunteers is not associated with the development of oxidative stress assessed by plasma F2-isoprostanes and isofurans
  82. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys
  83. Serum 25-hydroxyvitamin D concentrations and cardiometabolic risk factors in adolescents and young adults
  84. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease
  85. Hypothalamic-pituitary-adrenal axis activity under resting conditions and cardiovascular risk factors in adolescents
  86. Specialised pro-resolving mediators of inflammation in inflammatory arthritis
  87. n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease
  88. Lipidomics Reveals Associations of Phospholipids With Obesity and Insulin Resistance in Young Adults
  89. Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening?
  90. The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes
  91. n-3 Fatty acid supplementation and proresolving mediators of inflammation
  92. Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
  93. Regular Fat and Reduced Fat Dairy Products Show Similar Associations with Markers of Adolescent Cardiometabolic Health
  94. Fish oil and multivitamin supplementation reduces oxidative stress but not inflammation in healthy older adults: A randomised controlled trial
  95. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n–3 fatty acids and aspirin
  96. Associations of maternal prepregnancy body mass index and gestational weight gain with cardio-metabolic risk factors in adolescent offspring: a prospective cohort study
  97. Randomized Controlled Intervention of the Effects of Alcohol on Blood Pressure in Premenopausal Women
  98. n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease
  99. Novel relationships between B12, folate and markers of inflammation, oxidative stress and NAD(H) levels, systemically and in the CNS of a healthy human cohort
  100. Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease
  101. Identification of a dietary pattern associated with greater cardiometabolic risk in adolescence
  102. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications
  103. Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: insights from a 20-year prospective follow-up birth cohort
  104. Use of the Dietary Guideline Index to assess cardiometabolic risk in adolescents
  105. An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
  106. Authors’ Response
  107. Contrasting effects of prenatal life stress on blood pressure and body mass index in young adults
  108. The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial
  109. Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats
  110. Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the Sun Exposure and Vitamin D Supplementation (SEDS) Study
  111. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors
  112. Lifecourse Adiposity and Blood Pressure Between Birth and 17 Years Old
  113. Effects of omega-3 and omega-6 fatty acids on human placental cytokine production
  114. Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents
  115. Higher breakfast glycaemic load is associated with increased metabolic syndrome risk, including lower HDL-cholesterol concentrations and increased TAG concentrations, in adolescent girls
  116. Supplementation with N-3 Long-Chain Polyunsaturated Fatty Acids or Olive Oil in Men and Women with Renal Disease Induces Differential Changes in the DNA Methylation of FADS2 and ELOVL5 in Peripheral Blood Mononuclear Cells
  117. Microparticles Mediate Hepatic Ischemia-Reperfusion Injury and Are the Targets of Diannexin (ASP8597)
  118. Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation
  119. Dairy product consumption, dietary nutrient and energy density and associations with obesity in Australian adolescents
  120. Vitamin D status and predictors of serum 25-hydroxyvitamin D concentrations in Western Australian adolescents
  121. The Comparison of Methods for Measuring Oxidative Stress in Zebrafish Brains
  122. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity
  123. Lower Fructose Intake May Help Protect Against Development of Nonalcoholic Fatty Liver in Adolescents With Obesity
  124. Preeclampsia and cardiovascular disease share genetic risk factors on chromosome 2q22
  125. Gender and the active smoking and high-sensitivity C-reactive protein relation in late adolescence
  126. Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage
  127. Fish Oil (SMOFlipid) and Olive Oil Lipid (Clinoleic) in Very Preterm Neonates
  128. Endothelial cationic amino acid transporter-1 overexpression can prevent oxidative stress and increases in arterial pressure in response to superoxide dismutase inhibition in mice
  129. Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age in Cerebrospinal Fluid
  130. Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors
  131. Early Infant Feeding and Adiposity Risk: From Infancy to Adulthood
  132. Rescue of glucocorticoid-programmed adipocyte inflammation by omega-3 fatty acid supplementation in the rat
  133. Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+ are linked to differences in plasma carotenoid concentrations
  134. Monoamine oxidase a gene polymorphisms common to blood pressure and depression scores in caucasian children
  135. Obesity, Metabolic Syndrome and Nutrition
  136. Isoprostanes and neuroprostanes: Total synthesis, biological activity and biomarkers of oxidative stress in humans
  137. Low vitamin D levels are associated with symptoms of depression in young adult males
  138. Echium oil is better than rapeseed oil in improving the response of barramundi to a disease challenge
  139. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial
  140. Dietary n-3 PUFA and CVD: a review of the evidence
  141. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents
  142. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults
  143. Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta
  144. Prospective associations between sugar-sweetened beverage intakes and cardiometabolic risk factors in adolescents
  145. Gender Difference in the Relationship between Passive Smoking Exposure and HDL-Cholesterol Levels in Late Adolescence
  146. The Western Dietary Pattern Is Prospectively Associated With Nonalcoholic Fatty Liver Disease in Adolescence
  147. Association Between Liver-Specific Gene Polymorphisms and Their Expression Levels With Nonalcoholic Fatty Liver Disease
  148. Fatty acids: Health Effects of Omega-6 Polyunsaturated Fatty Acids
  149. Maternal Dietary Omega-3 Fatty Acid Supplementation Reduces Placental Oxidative Stress and Increases Fetal and Placental Growth in the Rat
  150. Dietary intake in population-based adolescents: support for a relationship between eating disorder symptoms, low fatty acid intake and depressive symptoms
  151. Low intake of B-vitamins is associated with poor adolescent mental health and behaviour
  152. Changes in Dairy Food and Nutrient Intakes in Australian Adolescents
  153. DNA methylation of the IGF2/H19 imprinting control region and adiposity distribution in young adults
  154. Early life programming of cardiometabolic disease in the Western Australian pregnancy cohort (Raine) study
  155. Dietary fructose in relation to blood pressure and serum uric acid in adolescent boys and girls
  156. Pre-pregnancy maternal overweight and obesity increase the risk for affective disorders in offspring
  157. Postnatal Fish Oil Supplementation in High-Risk Infants to Prevent Allergy: Randomized Controlled Trial
  158. 976 20-HETE IS ELEVATED IN PLASMA AND ASSOCIATES WITH RAISED BLOOD PRESSURE IN PREECLAMPSIA
  159. Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity
  160. Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid Supplementation
  161. Fish oil supplementation in early infancy modulates developing infant immune responses
  162. Oral contraceptive use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence
  163. Allergic disease in the first year of life is associated with differences in subsequent neurodevelopment and behaviour
  164. Sex Dimorphism in the Relation between Early Adiposity and Cardiometabolic Risk in Adolescents
  165. Reduced metal ion concentrations in atherosclerotic plaques from subjects with Type 2 diabetes mellitus
  166. Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans
  167. Associations between anxious-depressed symptoms and cardiovascular risk factors in a longitudinal childhood study
  168. Associations between aggressive behaviour scores and cardiovascular risk factors in childhood
  169. Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation–Myocardial Infarction
  170. The BACE1-PSEN-AβPP Regulatory Axis has an Ancient Role in Response to Low Oxygen/Oxidative Stress
  171. Is There a Role for Isofurans and Neuroprostanes in Pre-Eclampsia and Normal Pregnancy?
  172. Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls
  173. Are Isofurans and Neuroprostanes Increased After Subarachnoid Hemorrhage and Traumatic Brain Injury?
  174. Loci affecting gamma-glutamyl transferase in adults and adolescents show age × SNP interaction and cardiometabolic disease associations
  175. Omega 3 Fatty Acid Supplements and Cardiovascular Health: Commentary on the article by de Jong et al. on page 411
  176. Hemoglobin attenuates the effects of inspired oxygen on plasma isofurans in humans during upper-limb surgery
  177. The Infant Fish Oil Supplementation Study (IFOS): Design and research protocol of a double-blind, randomised controlled n−3 LCPUFA intervention trial in term infants
  178. Differential relationships between anthropometry measures and cardiovascular risk factors in boys and girls
  179. Lupin and soya reduce glycaemia acutely in type 2 diabetes
  180. Effects of spinal or general anesthesia on F2-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery
  181. Dietary intake of omega-3 fatty acids and risk of depressive symptoms in adolescents
  182. Association of Genetic Loci With Glucose Levels in Childhood and Adolescence: A Meta-Analysis of Over 6,000 Children
  183. Lifecourse Childhood Adiposity Trajectories Associated With Adolescent Insulin Resistance
  184. Gender-Specific Differences in Adipose Distribution and Adipocytokines Influence Adolescent Nonalcoholic Fatty Liver Disease Δ
  185. Polyunsaturated fatty acid intake and blood pressure in adolescents
  186. Recent advances in understanding the role and use of marine ω3 polyunsaturated fatty acids in cardiovascular protection
  187. Dietary intake and food sources of fatty acids in Australian adolescents
  188. Relative validity of adolescent dietary patterns: a comparison of a FFQ and 3 d food record
  189. The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function
  190. Essential fatty acids and mood: A systematic review of observational studies
  191. Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review
  192. Omega-3 Index Correlates with Healthier Food Consumption in Adolescents and with Reduced Cardiovascular Disease Risk Factors in Adolescent Boys
  193. The Effects of a Lupin-Enriched Diet on Oxidative Stress and Factors Influencing Vascular Function in Overweight Subjects
  194. Effects of lupin-enriched foods on body composition and cardiovascular disease risk factors: a 12-month randomized controlled weight loss trial
  195. Coenzyme Q10 and Statin Myalgia: What is the Evidence?
  196. A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates
  197. Equivalent lipid oxidation profiles in advanced atherosclerotic lesions of carotid endarterectomy plaques obtained from symptomatic type 2 diabetic and nondiabetic subjects
  198. Dietary glycaemic carbohydrate in relation to the metabolic syndrome in adolescents: comparison of different metabolic syndrome definitions
  199. The omega-3 fatty acids EPA and DHA decrease plasma F2-isoprostanes: Results from two placebo-controlled interventions
  200. Dietary patterns and markers for the metabolic syndrome in Australian adolescents
  201. Effects of Sepiapterin Supplementation and NOS Inhibition on Glucocorticoid-Induced Hypertension
  202. Antioxidant Defenses in the Rat Placenta in Late Gestation: Increased Labyrinthine Expression of Superoxide Dismutases, Glutathione Peroxidase 3, and Uncoupling Protein 2
  203. Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
  204. Effects of increasing dietary protein and fibre intake with lupin on body weight and composition and blood lipids in overweight men and women
  205. Developmental programming of adult adrenal structure and steroidogenesis: effects of fetal glucocorticoid excess and postnatal dietary omega-3 fatty acids
  206. Measurement of urinary F2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances
  207. Parenteral Lipid Emulsions Based on Olive Oil Compared With Soybean Oil in Preterm (<28 Weeks' Gestation) Neonates: A Randomised Controlled Trial
  208. Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
  209. Flaxseed Oil Supplementation Increases Plasma F1-Phytoprostanes in Healthy Men ,
  210. The effects of ω3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial
  211. The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension
  212. Skim milk compared with a fruit drink acutely reduces appetite and energy intake in overweight men and women
  213. Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation
  214. HDL is the major lipoprotein carrier of plasma F2-isoprostanes
  215. Effects of lupin kernel flour–enriched bread on blood pressure: a controlled intervention study
  216. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study
  217. Synergy Between Adiposity, Insulin Resistance, Metabolic Risk Factors, and Inflammation in Adolescents
  218. 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction
  219. Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population
  220. Tolerability and safety of olive oil–based lipid emulsion in critically ill neonates: A blinded randomized trial
  221. N‐ACETYLCYSTEINE PREVENTS BUT DOES NOT REVERSE DEXAMETHASONE‐INDUCED HYPERTENSION
  222. Developmental programming of adult hyperinsulinemia, increased proinflammatory cytokine production, and altered skeletal muscle expression of SLC2A4 (GLUT4) and uncoupling protein 3
  223. Glutathionyl haemoglobin is not increased in diabetes nor related to glycaemia, complications, dyslipidaemia, inflammation or other measures of oxidative stress
  224. Long-term follow-up of participants in a health promotion program for treated hypertensives (ADAPT)
  225. An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population
  226. ARACHIDONIC ACID METABOLISM IN GLUCOCORTICOID‐INDUCED HYPERTENSION
  227. Increased serum pigment epithelium‐derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes1
  228. Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils
  229. Induction of Heme Oxygenase-1 In Vivo Suppresses NADPH Oxidase–Derived Oxidative Stress
  230. Moderators and mediators of behaviour change in a lifestyle program for treated hypertensives: a randomized controlled trial (ADAPT)
  231. Association of maternal smoking with increased infant oxidative stress at 3 months of age
  232. A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men
  233. Changes in cognitive measures associated with a lifestyle program for treated hypertensives: a randomized controlled trial (ADAPT)
  234. Retinol supplementation in murine Plasmodium berghei malaria: Effects on tissue levels, parasitaemia and lipid peroxidation
  235. Impact of foods enriched withn-3 long-chain polyunsaturated fatty acids on erythrocyten-3 levels and cardiovascular risk factors
  236. Folic Acid Prevents and Partially Reverses Glucocorticoid-Induced Hypertension in the Rat
  237. A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial
  238. Supplementation with vitamins C, E, β‐carotene and selenium has no effect on anti‐oxidant status and immune responses in allergic adults: a randomized controlled trial
  239. Dietary Fats and Blood Pressure
  240. Antioxidant Vitamins and Adrenocorticotrophic Hormone-Induced Hypertension in Rats
  241. Associations between antioxidant status, markers of oxidative stress and immune responses in allergic adults
  242. n− 3 Fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids
  243. INTRODUCTION
  244. Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency
  245. OMEGA‐3 FATTY ACIDS AND HYPERTENSION IN HUMANS
  246. Associations between antioxidant status, markers of oxidative stress and immune responses in allergic adults
  247. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging
  248. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans
  249. Prevention of Programmed Hyperleptinemia and Hypertension by Postnatal Dietary ω-3 Fatty Acids
  250. The Use of Novel Foods Enriched with Long-Chain n-3 Fatty Acids to Increase Dietary Intake: A Comparison of Methodologies Assessing Nutrient Intake
  251. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy
  252. Processes Involved in the Site-Specific Effect of Probucol on Atherosclerosis in Apolipoprotein E Gene Knockout Mice
  253. Apocynin but Not Allopurinol Prevents and Reverses Adrenocorticotropic Hormone-Induced Hypertension in the Rat
  254. Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial
  255. Induced Sputum 8-Isoprostane Concentrations in Inflammatory Airway Diseases
  256. Omega-3 fatty acids and inflammation
  257. Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects
  258. Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation
  259. Fish Oil Supplementation in Pregnancy Lowers F2-isoprostanes in Neonates at High Risk of Atopy
  260. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat
  261. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition
  262. Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle
  263. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy
  264. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects
  265. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat
  266. Macronutrients. Fiber, Cholesterol and Dietary Patterns
  267. Dietary W3 Fatty Acids
  268. Dietary W3 Fatty Acids
  269. Maternal fish oil supplementation in pregnancy reduces interleukin‐13 levels in cord blood of infants at high risk of atopy
  270. Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients
  271. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients
  272. An innovative program for changing health behaviours
  273. Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration
  274. Regulatory Effects of HMG CoA Reductase Inhibitor and Fish Oils on Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Male Subjects With Dyslipidemia
  275. Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension
  276. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity
  277. Similarity in the distribution of F2-isoprostanes in the lipid subfractions of atherosclerotic plaque andin vitrooxidised low density lipoprotein
  278. Mechanism of Action of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor on Apolipoprotein B-100 Kinetics in Visceral Obesity
  279. Mechanism of Action of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor on Apolipoprotein B-100 Kinetics in Visceral Obesity
  280. Coenzyme Q10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus
  281. Acute effects of ingestion of black tea on postprandial platelet aggregation in human subjects
  282. Erratum to: Advanced glycation end-products: a review
  283. Recent Developments Concerning Diet And Hypertension
  284. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans
  285. Study of Plasma Factors Associated With Neutrophil Activation and Lipid Peroxidation in Preeclampsia
  286. Oxidant stress in nephrotic syndrome: comparison of F2‐isoprostanes and plasma antioxidant potential
  287. Dietary Cosupplementation With Vitamin E and Coenzyme Q 10 Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice
  288. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects
  289. Advanced glycation end-products: a review
  290. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction
  291. Non Pharmacologic Therapy and Lifestyle Factors in Hypertension
  292. Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Vascular Reactivity of the Forearm Microcirculation in Hyperlipidemic, Overweight Men
  293. Effect of ω3 fatty acids on oxidative stress in humans: GC–MS measurement of urinary F2-isoprostane excretion
  294. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non—insulin-dependent diabetic patients
  295. Fish oils, dyslipidaemia and glycaemic control in diabetes
  296. Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans
  297. Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry
  298. Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure
  299. Comparison of the effects of black and green tea onin vitro lipoprotein oxidation in human serum
  300. An Improved Method for the Measurement of Urinary and Plasma F2-Isoprostanes Using Gas Chromatography–Mass Spectrometry
  301. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels A randomized controlled trial
  302. Effects of Dietary Fish and Weight Reduction on Ambulatory Blood Pressure in Overweight Hypertensives
  303. The Independent and Combined Effects of Aerobic Exercise and Dietary Fish Intake on Serum Lipids and Glycemic Control in NIDDM: A randomized controlled study
  304. Interactions Between Dietary Fat, Fish, and Fish Oils and Their Effects on Platelet Function in Men at Risk of Cardiovascular Disease
  305. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum
  306. Analysis of native and oxidized low-density lipoprotein oxysterols using gas chromatography—mass spectrometry with selective ion monitoring
  307. Absence of increased susceptibility of LDL to oxidation in type 1 diabetics
  308. EFFECTS OF GARLIC EXTRACT ON PLATELET AGGREGATION: A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY
  309. Erratum. New Cembrene Diterpenes from the Resins of Eremophila Species
  310. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease
  311. New Cembrene Diterpenes from the Resins of Eremophila Species
  312. Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease.
  313. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation
  314. Differential Effect of Aspirin on Platelet Aggregation in IDDM
  315. URINARY STEROID PROFILES AND ALOCHOL-RELATED BLOOD PRESSURE ELEVATION
  316. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics
  317. Fish Oil-Induced Changes in Apolipoproteins in IDDM Subjects
  318. Dietary fish oils increase serum lipids in insulin-dependent diabetics compared with healthy controls
  319. Sesquiterpenes from Laurencia spp.
  320. SERUM LIPIDS IN INSULIN-DEPENDENT DIABETICS ARE MARKEDLY ALTERED BY DIETARY FISH OILS
  321. New findings in the fatty acid composition of individual platelet phospholipids in man after dietary fish oil supplementation
  322. CAN THE SYNTHESIS OF PLATELET‐ACTIVATING FACTOR, A POTENT VASODILATOR AND PRO‐AGGREGATORY AGENT, BE ALTERED BY DIETARY MARINE OILS?
  323. The Chemistry of Eremophila Spp. XXV. New Cembrene Derivatives From E. dempsteri, E. platycalyx and E. fraseri
  324. A new class of macrocyclic diterpenes from (euphorbiaceae)
  325. The Chemistry of Eremophila spp. XX. The Absolute Stereochemistry of the Viscidane Diterpenes
  326. The chemistry of Eremophila spp. XXI. Structural study of a new eremane diterpene
  327. The chemistry of Eremophila spp. XIX. New cembrane diterpenes from E. granitica and E. abietina